Primary Care

Group co-leader: Itziar Vergara Micheltorena, Ph.D.

Donostialdea IHO E-mail itziar.vergaramitxeltorena@osakidetza.eus

Group co-leader: Rafael Rotaeche del Campo

Biogipuzkoa HRI E-mail rafaeljesusmaria.rotaechedelcampo@osakidetza.eus
Itziar Vergara Micheltorena, has a Degree in Medicine, is a specialist in Family and Community Medicine, has a Master of Public Health from the University of California, Berkeley and qualified as a Doctor in Medicine at the University of the Basque Country (UPV/EHU). Between 2011 and 2023, she has been Leader of the Unit on Research in Primary Care and IHOs in Gipuzkoa. She is a member of the Spanish Health Services and Chronic Diseases Research Network, REDISSEC, Leader of the Primary Care Research Group and head of the frailty research line of the Biodonostia HRI Strategy of Research in Ageing. She is currently directing two doctoral thesis. She is the Principal Researcher on several projects at autonomous, national and international level and the author of 60 articles, as well as the co-inventor of two patents related to the promotion of healthy ageing and dealing with frailty in primary care. Rafael Rotaeche del Campo has a Degree in Medicine, specialising in Family and Community Medicine, as well as a Master’s Degree in Primary Healthcare Research completed at the Universidad Miguel Hernández (Elche). Since June 2023, she has been Head of the Unit promoting research into the Primary Healthcare and Integrated Health Organisations (IHOs) of Gipuzkoa. Dr Rotaeche is a member of the Research Network on Chronicity, Primary Healthcare & Prevention and Health Promotion (RICAPPS), and of the Guiasalud scientific committee. She is also coordinator of the semFYC group on evidence-based medicine (EBM) and member of the Fisterra editorial team. She has combined her work providing Primary Healthcare with teaching and research, and is principal and associate researcher on numerous projects studying common Primary Healthcare problems such as diabetes, the use of antibiotics, polypharmacy and prudent prescribing. A contributor to the design and implementation of Clinical Practice Guidelines (CPG), she has written and coordinated several of these both at Osakidetza and as part of the national programme on CPG. She is the author of more than 40 scientific publications and has given myriad talks at congresses on these subjects.

Objectives and lines

The Basque Public Health Service has a primary care network which constitutes the entrance door to the health system for citizens and represents one of its greatest strengths in regard to accessibility and the ability to solve most of the population’s health problems. The service provides integrating and continuous care, both necessary conditions for effectively and efficiently caring for chronicity.

The added value of the Primary Care (PC) research integrated to the new IHO structures is determined by a series of factors typical of this area of care: Patient-focused care and holistic focus; Competences in solving clinical problems; Integral focus; Management of primary health care and Community orientation.

The very nature of the sphere represented in this proposal establishes its scope and its variety. The possible research lines are countless and, given the experience and quality of professionals in the region of Gipuzkoa, the work proposal of this group is broad and varied.

These are the main lines of work and their associated objectives:

Line 1: Integral approach to patients with chronic diseases

Our organisation’s model change must address the best way to provide health care to patients with chronic diseases and different degrees of complexity. This means generating knowledge on the most efficient way to proceed.

Disease self-management and patient enablement

  • Study of the possibilities of introducing programmes for the self-management of chronic disease in our environment
  • Design studies to analyse the effectiveness of disease self-management
  • Identify elements of success in disease self-management programmes

Adjustment of pharmacological treatment, of preventive strategies and of risk factor control

  • Place priority on recommendations based on evidence of preventive strategies, risk factor control and the adjustment of pharmacological treatment in elderly patients and/or those with multimorbility
  • Identify avoidable iatrogenic effects associated to the more frequent treatments in elderly patients and/or those with multimorbility and place priority on the main problems
  • Design interventions to implement priority recommendations in regard to preventive strategies, adjustment of treatment and avoidable iatrogenic effects in the context of the integrated organisations
  • Evaluate the impact of interventions in normal clinical practice conditions

Integral approach to fragility

  • Design appropriate instruments for their use in PC-OHIs with a view to identifying fragile subjects
  • Analyse the determining factors of fragility
  • Design interventions to reverse fragility

Line 2: PC strategies and diagnostic tests: validation and analysis of their adjustment

  • Identify appropriate diagnostic tests for their application in PC and adapt them to the PC environment
  • Develop, validate and evaluate the applicability of CPR in the PC environment

Team Members

Name Surname Center E-mail
Ivan Antón Rodrigo OSI Debabarrena ivan.antonrodrigo@osakidetza.eus
Uxune Apalategi Gómez Unidad docente multiprofesional de atención primaria y comunitaria de Gipuzkoa uxune.apalateguigomez@osakidetza.eus
Iosu Barral Juez OSI Donostialdea iosu.barraljuez@osakidetza.eus
Ana Díez Ruiz OSI Donostialdea anaisabeldiezruiz@osakidetza.eus
Arritxu Etxeberria Agirre OSI Donostialdea arritxu.etxeberriaagirre@osakidetza.eus
Estíbaliz Gamboa Moreno OSI Donostialdea estibaliz.gamboamoreno@osakidetza.eus
Ana Isabel Garaikoetxea Iturriria OSI Donostialdea anaisabel.garaikoetxeaiturriria@osakidetza.eus
Raquel González Miguel OSI Donostialdea raquel.gonzalezmiguel@osakidetza.eus
Carolina Güell Pelayo OSI Donostialdea carolina.guellpelayo@osakidetza.eus
Maria Angeles Gutierrez Stampa OSI Donostialdea mariaangeles.gutierrezstampa@osakidetza.eus
Miriam Hernández González Biogipuzkoa HRI miriam.hernandezgonzalez@bio-gipuzkoa.eus
Maider Mateo Abad Biogipuzkoa HRI maider.mateoabad@bio-gipuzkoa.eus
Kalliopi Vrotsou Kanari Unidad de investigación AP OSIs Gipuzkoa kalliopi.vrotsoukanari@osakidetza.eus

Scientific Output

PLATAFORMA BIOBANCOS Y BIOMODELOS
Código: PT20/00111/BD
Investigador Principal (IP): ITZIAR VERGARA MICHELTORENA
Entidad Financiadora: ISCIII INSTITUTO DE SALUD CARLOS III
Fecha de Inicio: 2021-01-01
Fecha de finalización: 2024-12-31
Importe Concedido: 20.500,00 €
BIODATAK ERAIKIZ
Código: 2023444001/BD
Investigador Principal (IP): MAIDER MATEO ABAD
Entidad Financiadora: DEPARTAMENTO DE SALUD
Fecha de Inicio: 2023-07-10
Fecha de finalización: 2023-12-31
Importe Concedido: 6.999,85 €
ESTUDIO COMPARATIVO SOBRE LA PREVALENCIA DE PLURIPATOLOGIA, POLIMEDICACION Y PRESCRIPCIONES POTENCIALMENTE INAPROPIADAS ENTRE LA POBLACION GENERAL Y VIH EN EUSKADI
Código: 2023111044
Investigador Principal (IP): MARIA ANGELES GUTIERREZ STAMPA
Entidad Financiadora: DEPARTAMENTO DE SALUD
Fecha de Inicio: 2023-12-01
Fecha de finalización: 2026-12-01
Importe Concedido: 27.798,71 €
COHORTE IMPACT EUSKADI: INFRAESTRUCTURA DE MEDICINA DE PRECISION ASOCIADA A LA CIENCIA Y TECNOLOGIA
Código: 2022111035/BD
Investigador Principal (IP): RAFAEL ROTAECHE DEL CAMPO
Entidad Financiadora: DEPARTAMENTO DE SALUD
Fecha de Inicio: 2022-10-01
Fecha de finalización: 2025-09-30
Importe Concedido: 67.123,47 €
EL RETO DE LA PREVENCION DEL DETERIORO COGNITIVO: DESDE LA EXPLORACION DE LAS RELACIONES COMPLEJAS DE SUS FACTORES DETERMINANTES A LA IDENTIFICACIÓN DE PERFILES DE RIESGO
Código: 2022-CIEN-000037-01
Investigador Principal (IP): ITZIAR VERGARA MICHELTORENA
Entidad Financiadora: DIPUTACION FORAL GIPUZKOA
Fecha de Inicio: 2022-05-05
Fecha de finalización: 2023-11-30
Importe Concedido: 157.978,00 €
COVID PERSISTENTE: SEGUIMIENTO DE CASOS DE LA PRIMERA OLA, UN AÑO TRAS LA INFECCION. DATOS A NIVEL DE LA CAPV
Código: 2022111028
Investigador Principal (IP): RAFAEL ROTAECHE DEL CAMPO
Entidad Financiadora: DEPARTAMENTO DE SALUD
Fecha de Inicio: 2022-11-02
Fecha de finalización: 2025-11-01
Importe Concedido: 37.631,00 €
MULTIMORBILIDAD EN EL SISTEMA NACIONAL DE SALUD: CARACTERIZACION POBLACIONAL E IMPACTO DE SUS PATRONES Y TRAYECTORIAS EN PERSONAS MAYORES (PROYECTO MM-SNS)
Código: PI22/01665
Investigador Principal (IP): ITZIAR VERGARA MICHELTORENA; RAFAEL ROTAECHE DEL CAMPO
Entidad Financiadora: ISCIII INSTITUTO DE SALUD CARLOS III
Fecha de Inicio: 2023-01-01
Fecha de finalización: 2025-12-31
Importe Concedido: 45.980,00 €
EVALUACION DE LAS ESTRATEGIAS DE DE-IMPLEMENTACION DE-IMFAR PARA FAVORECER EL ABANDONO DE PRESCRIPCIONES FARMACOLOGICAS DE BAJO VALOR EN PREVENCION PRIMARIA DE LA ENFERMEDAD CARDIOVASCULAR: ENSAYO DE IMPLEMENTACIÓN CON MÉTODOS MIXTOS
Código: 2021111024/BD
Investigador Principal (IP): RICARDO SAN VICENTE BLANCO; RAFAEL ROTAECHE DEL CAMPO
Entidad Financiadora: DEPARTAMENTO DE SALUD
Fecha de Inicio: 2021-10-01
Fecha de finalización: 2024-06-14
Importe Concedido: 5.439,74 €
CITA GO-ON: MODELO DE INTERVENCION MULTIMODAL DE PREVENCION DE DEMENCIA CENTRADO EN LA PERSONA, DIGITAL, INTERGENERACIONAL Y RENTABLE PARA GUIAR LAS POLITICAS ESTRATEGICAS QUE ENFRENTAN LOS DESAFIOS DEMOGRAFICOS DEL ENVEJECIMIENTO PROGRESIVO
Código: PLEC2021-008171
Investigador Principal (IP): JAVIER MAR MEDINA; MAIDER MATEO ABAD
Entidad Financiadora: MINISTERIO DE CIENCIA E INNOVACION
Fecha de Inicio: 2021-07-01
Fecha de finalización: 2025-12-31
Importe Concedido: 57.817,00 €
RICORS-REDES DE INVESTIGACION COOPERATIVA ORIENTADA A RESULTADOS EN SALUD-ITZIAR VERGARA
Código: RD21/0016/0021
Investigador Principal (IP): ITZIAR VERGARA MICHELTORENA
Entidad Financiadora: ISCIII INSTITUTO DE SALUD CARLOS III
Fecha de Inicio: 2022-01-01
Fecha de finalización: 2024-12-31
Importe Concedido: 136.649,70 €
DINAMIZACION E INNOVACION DE LAS CAPACIDADES INDUSTRIALES DEL SNS Y SU TRANSFERENCIA AL SECTOR PRODUCTIVO
Código: PT20/00019
Investigador Principal (IP): ITZIAR VERGARA MICHELTORENA
Entidad Financiadora: ISCIII INSTITUTO DE SALUD CARLOS III
Fecha de Inicio: 2021-01-01
Fecha de finalización: 2024-12-31
Importe Concedido: 412.500,00 €
OPTIMIZANDO LA VALORACION DE LA FUNCION Y DEL DOLOR EN LA ARTICULACION DEL HOMBRO
Código: 2019111019
Investigador Principal (IP): KALLIOPI VROTSOU
Entidad Financiadora: DEPARTAMENTO DE SALUD
Fecha de Inicio: 2019-11-30
Fecha de finalización: 2024-04-27
Importe Concedido: 5.661,00 €
TB-MED. AN OPEN INNOVATION TESTING BED FOR THE DEVELOPMENT OF HIGH-RISK MEDICAL DEVICES.
Código: UE/18/H2020/NMBP/TB-MED/BD
Investigador Principal (IP): JULIO ARRIZABALAGA AGUIRREAZALDEGUI; ITZIAR VERGARA MICHELTORENA
Entidad Financiadora: COMISION EUROPEA - HORIZON 2020
Fecha de Inicio: 2019-01-01
Fecha de finalización: 2023-08-31
Importe Concedido: 180.268,75 €
ABORDAJE DE LA FRAGILIDAD EN ATENCION PRIMARIA: EVALUACION DE LA EFECTIVIDAD DE UNA INTERVENCION MULTIFACTORIAL MEDIANTE UN ENSAYO CLINICO ALEATORIZADO. SUBPROYECTO1
Código: PI18/01558
Investigador Principal (IP): ITZIAR VERGARA MICHELTORENA
Entidad Financiadora: ISCIII INSTITUTO DE SALUD CARLOS III
Fecha de Inicio: 2019-01-01
Fecha de finalización: 2023-06-30
Importe Concedido: 45.980,00 €